centruroides (scorpion) immune f(ab')2 (equine) injection
Trade name: Anascorp
Animal productapprovedOrphan Drug FDA
Approved
Aug 3, 2011
Clinical trial activity
6 trials · 8 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
6
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT01599936)
Timeline
2000s
2010s
- Aug 3, 2011
Rare Disease Therapeutics — Earliest FDA Approval
- Aug 3, 2011
Rare Disease Therapeutics — NDA Organization
Indications
Approved for
Mechanism of action
- scorpion toxinImmunity, passive
scorpion toxin immunity, passive
Approval history
- approvedAug 3, 2011
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSDDA050FCEA ↗
Also known as
- alacramyn
- anascorp
- anascorp
- antivenin centruroides (scorpion) equine immune f(ab')2
- centruroides (scorpion) immune f(ab')2 (equine) injection
- equine f(ab')2 antivenom
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01336660 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2017 | Centre Antipoison et de Pharamacovigilance du Maroc, FES University Hospital, Instituto Bioclon, Institut Pasteur |
| NCT01415830 | Phase 3 | Aug 1, 2011 | Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. |
| NCT00624078 | Phase 2/Phase 3 (Phase 3) | May 1, 2005 | Instituto Bioclon, University of Arizona |
| NCT01599923 | Phase 3 | May 1, 2005 | Children's Hospital of Morelos, Instituto Bioclon, National Autonomous University of Mexico, University of Arizona |
| NCT00685230 | Phase 2/Phase 3 (Phase 3) | May 1, 2004 | Instituto Bioclon, National Autonomous University of Mexico, University of Arizona |
| NCT01599936 | Phase 3 | Apr 1, 2004 | Instituto Bioclon, National Autonomous University of Mexico, University of Arizona |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Instituto Bioclon | For profit | 5 | 5 | 1 | 2004 |
| University of Arizona | Academic/Hospital | 4 | 0 | 1 | 2004 |
| National Autonomous University of Mexico | Academic/Hospital | 3 | 0 | 1 | 2004 |
| Centre Antipoison et de Pharamacovigilance du Maroc | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Children's Hospital of Morelos | Academic/Hospital | 1 | 0 | 1 | 2005 |
| FES University Hospital | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Institut Pasteur | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. | Academic/Hospital | 1 | 1 | 1 | 2011 |
8 organizations
Page 1 / 1
Marketing (1)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Rare Disease Therapeutics | For profit | NDA | Aug 3, 2011 |